send to a friend by email
2024-02-26
According to the financial statements of Birzeit Pharmaceuticals Company BPC for the year 2023, Net profit after tax of the period reached 6,153,724 USD Compared with Net profit after tax 7,934,039 USD for 2022, a net decrease in profit of 22.44%.Total assets of the company reached 125,146,969 USD compared with total assets of 123,003,262 USD at the end of year 2022, a net increase of 1.74%.Total liabilities of the company reached 20,122,207 USD compared with total liabilities of 19,489,454 USD at the end of year 2022, a net increase of 3.24%. Net ownership equity of the company reached 105,024,762 USD (Including Non-Controlling Interests of 700,373 USD) compared with total owner equity of 103,513,808 USD (Including Non-Controlling Interests of 923,623 USD) at the end of year 2022, a net increase of 1.46%.
|
|